Cargando…

STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation

Large granular lymphocyte leukemia (LGLL) is characterized by somatic gain-of-function STAT3 mutations. However, the functional effects of STAT3 mutations on primary LGLL cells have not been studied in detail. In this study, we show that CD8+ T cells isolated from STAT3 mutated LGLL patients have hi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Daehong, Park, Giljun, Huuhtanen, Jani, Ghimire, Bishwa, Rajala, Hanna, Moriggl, Richard, Chan, Wing C., Kankainen, Matti, Myllymäki, Mikko, Mustjoki, Satu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632689/ https://www.ncbi.nlm.nih.gov/pubmed/34075200 http://dx.doi.org/10.1038/s41375-021-01296-0

Ejemplares similares

Somatic STAT3 mutations in CD8(+) T cells of healthy blood donors carrying human T-cell leukemia virus type 2
por: Kim, Daehong, et al.
Publicado: (2021)

Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8(+) T-cell large granular lymphocytic leukemia
por: Huuhtanen, Jani, et al.
Publicado: (2022)

Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease
por: Kim, Daehong, et al.
Publicado: (2020)

Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia
por: Bhattacharya, Dipabarna, et al.
Publicado: (2022)

STAT5b in LGL leukemia – a novel therapeutic target?
por: Rajala, Hanna L. M., et al.
Publicado: (2013)

Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia
por: Lundgren, Sofie, et al.
Publicado: (2021)

Predicting recognition between T cell receptors and epitopes with TCRGP
por: Jokinen, Emmi, et al.
Publicado: (2021)

Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation
por: Andersson, E I, et al.
Publicado: (2013)

Somatic mutations and T-cell clonality in patients with immunodeficiency
por: Savola, Paula, et al.
Publicado: (2019)

Somatic STAT3 mutations in Felty syndrome: an implication for a common pathogenesis with large granular lymphocyte leukemia
por: Savola, Paula, et al.
Publicado: (2018)

SBNO2 is a critical mediator of STAT3-driven hematological malignancies
por: Brandstoetter, Tania, et al.
Publicado: (2023)

RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses
por: Adnan Awad, Shady, et al.
Publicado: (2020)

Twins with different personalities: STAT5B—but not STAT5A—has a key role in BCR/ABL-induced leukemia
por: Kollmann, Sebastian, et al.
Publicado: (2019)

TCRconv: predicting recognition between T cell receptors and epitopes using contextualized motifs
por: Jokinen, Emmi, et al.
Publicado: (2022)

Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature
por: Kelkka, Tiina, et al.
Publicado: (2020)

Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature
por: Kelkka, Tiina, et al.
Publicado: (2021)

Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling
por: Kuusanmäki, Heikki, et al.
Publicado: (2017)

Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets
por: Adnan-Awad, Shady, et al.
Publicado: (2020)

S176: FUNCTIONAL AND ANTIGEN-SPECIFIC CHARACTERIZATION OF IMMUNE CELLS AT THE SINGLE-CELL LEVEL REVEALS CONVERGENCE OF ADAPTIVE AND INNATE IMMUNITY IN IMMUNE APLASTIC ANEMIA
por: Huuhtanen, Jani, et al.
Publicado: (2023)

Cytokines in the Pathogenesis of Large Granular Lymphocytic Leukemia
por: Isabelle, Colleen, et al.
Publicado: (2022)

JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
por: Erdogan, Fettah, et al.
Publicado: (2022)

Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia
por: Kelkka, Tiina, et al.
Publicado: (2022)

Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma
por: Lee, Moon Hee, et al.
Publicado: (2023)

A novel class of somatic mutations in blood detected preferentially in CD8 + cells
por: Valori, Miko, et al.
Publicado: (2017)

Large granular lymphocyte leukemia serum and corresponding hematological parameters reveal unique cytokine and sphingolipid biomarkers and associations with STAT3 mutations
por: Olson, Kristine C., et al.
Publicado: (2020)

Evolution and modulation of antigen-specific T cell responses in melanoma patients
por: Huuhtanen, Jani, et al.
Publicado: (2022)

Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation
por: Adnan Awad, Shady, et al.
Publicado: (2022)

The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma
por: Schönefeldt, Susann, et al.
Publicado: (2021)

T and NK cell abundance defines two distinct subgroups of renal cell carcinoma
por: Lee, Moon Hee, et al.
Publicado: (2022)

Genomic landscape characterization of large granular lymphocyte leukemia with a systems genetics approach
por: Coppe, A, et al.
Publicado: (2017)

Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
por: Flanagan, Sarah E., et al.
Publicado: (2014)

STAT3 Mutation Is Associated with STAT3 Activation in CD30(+) ALK(−) ALCL
por: Andersson, Emma I., et al.
Publicado: (2020)

Methotrexate therapy of T-cell large granular lymphocytic leukemia impact of STAT3 mutation
por: Qiu, Zhi-Yuan, et al.
Publicado: (2016)

Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic Leukemia
por: Hohtari, Helena, et al.
Publicado: (2022)

Distinguishing STAT3/STAT5B-mutated large granular lymphocyte leukemia from myeloid neoplasms by genetic profiling
por: Kavesh, Mark, et al.
Publicado: (2022)

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target
por: Dufva, Olli, et al.
Publicado: (2018)

Targeting STAT3 and STAT5 in Cancer
por: de Araujo, Elvin D., et al.
Publicado: (2020)

The tumor and plasma cytokine profiles of renal cell carcinoma patients
por: Lee, Moon Hee, et al.
Publicado: (2022)

T-cell large granular lymphocyte leukemia: an Asian perspective
por: Kwong, Yok-Lam, et al.
Publicado: (2010)

STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia
por: Ishida, Fumihiro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0sticfaeiijl1ps8t0vae3tf3h